Comparison of the effect of kalsitrapine and metformin as adjunctive therapy in the treatment of infertility in women with polycystic ovary syndrome
Abstract
Background: Chronic anovulation is one of the most common causes of infertility. In women with polycystic ovary syndrome (PCOS), other factors related to oocyte quality or endometrial and nesting disorders may also play a role. Infertile and non-ovulatory women who tend to become pregnant are candidates for ovulation induction. The aim of this study was to evaluate the effect of Kalsitrapine and metformin on the treatment of patients with PCOS.Methods: The clinical trial study was performed on 80 female patients with PCOS who had referred to Ardabil city hospital for infertility treatment were randomly divided in two groups with personal consent. One group received Kalsitrapine and another group received metformin.Results: The mean age of all patients was 26.08±5.21. There was no significant difference between 2 groups in term of age and BMI. There was no statistically significant difference between the two groups in terms of primary and secondary infertility. The mean duration of infertility was 3.68±3.49 years. There was no statistically significant difference between the 2 groups in terms of infertility duration. There was no statistically significant difference between the 2 groups in terms of the type of menstrual cycle. The response rate to treatment was 17.5% in the metformin group and 10% in the Kalsitrapine group. There was no statistically significant difference between the 2 groups in terms of response to treatment. In comparison, none of the studied factors in…
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.